Diagnostics, Infection
The company is a medical devices company that has developed advanced protein based technology for use in diagnostic sensors and antimicrobial therapies. The company’s diagnostic […]
Uterine Fibroids
The company is a medical device company that focuses on actualizing technological products for women’s health. Currently the company is developing a minimally invasive therapeutic […]
[Company Profile] Altea Therapeutics
One of the more impressive companies at the IN3 West conference was Altea Therapeutics, an Atlanta-based clinical stage company involved in drug delivery.
IN3 East Is Almost Here
Join us next month at IN3 East 2010 in Boston, aimed at partnering a global audience of VCs, top investors, and corporate acquirers with early-/mid-/late-stage, medical technology start-ups and revolutionary innovators.
New National Drug Abuse Strategy Emphasizes Prevention
On May 11, the Obama administration unveiled its 2010 National Drug Control Strategy to reduce illicit drug use in America.
[Company Profile] NeoVista
The company is focused on the development of medical technologies that to treat wet age-related macular degeneration (AMD).
Valuable Take-Aways From IN3 West
IN3 West held an investor conference in Las Vegas with the title of “Investment in Innovation.” IN3 Conferences take place around the country and are developed by Elsevier Business Intelligence, which publishes the highly regarded industry report In Vivo.
FDA Hopes to Keep Pharma Honest With “Bad Ad” Program
Last week, the FDA unveiled its “Bad Ad” program to encourage physicians to report questionable pharmaceutical sales pitches.
OneMedForum to Cover Translational Research, European Market
A dedicated company presentation track for regional Translational Research will be presented at the June 30th OneMedForum at the Roosevelt Hotel in midtown Manhattan.
Health 2.0 Goes to Washington: June 7, 2010
Health 2.0 Goes to Washington, a one-day event introducing the Health 2.0 community to D.C., is almost here!